Bliss GVS Pharma Ltd

Bliss GVS Pharma Ltd

₹ 104 0.09%
24 Jun - close price
About

Incorporated in 1984, Bliss GVS Pharma Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups.

Key Points

Product Portfolio:
a) Pharma Products:[1]
Capsules, Creams/Gels/Ointments, Dry Powder for Injection and for Oral Suspension, Eye/Ear Drops, Effervescent tablets, Lotions, Injections, Liquid Preparations, Lozenges, Nasal Solutions, Oral Solids, Parenteral, etc.
b) Other Healthcare Products:[2]
Balm, Cream, Lotion, OTC products, Petroleum Jelly, Powder, Roll On
c) Therapeutics:[3]
Analgesic, Antacid, Anti-malarial, Anti-fungal, Anti-bacterial, Anti-biotic, Anti-inflammatory, Anti-diarrheic, anti-diabetic, etc.

  • Market Cap 1,089 Cr.
  • Current Price 104
  • High / Low 150 / 75.4
  • Stock P/E 11.6
  • Book Value 92.4
  • Dividend Yield 0.48 %
  • ROCE 14.4 %
  • ROE 10.2 %
  • Face Value 1.00

Pros

  • Stock is trading at 1.13 times its book value

Cons

  • The company has delivered a poor sales growth of -3.04% over past five years.
  • Promoter holding is low: 35.0%
  • Company has a low return on equity of 7.46% over last 3 years.
  • Company has high debtors of 192 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
132.05 168.15 195.99 216.26 167.06 188.66 172.43 205.72 184.78 159.52 211.88 200.72 198.13
115.17 133.55 166.58 182.10 146.90 149.81 147.88 158.04 178.55 135.31 157.51 157.02 169.78
Operating Profit 16.88 34.60 29.41 34.16 20.16 38.85 24.55 47.68 6.23 24.21 54.37 43.70 28.35
OPM % 12.78% 20.58% 15.01% 15.80% 12.07% 20.59% 14.24% 23.18% 3.37% 15.18% 25.66% 21.77% 14.31%
6.33 7.82 5.45 -67.55 12.19 7.01 2.15 5.65 2.98 5.11 12.60 5.42 -23.60
Interest 2.36 1.40 0.68 1.04 1.63 2.11 1.91 1.26 5.08 1.49 1.45 2.12 1.85
Depreciation 4.27 4.33 4.30 4.43 4.27 4.55 4.60 4.64 4.88 6.19 6.39 6.95 6.85
Profit before tax 16.58 36.69 29.88 -38.86 26.45 39.20 20.19 47.43 -0.75 21.64 59.13 40.05 -3.95
Tax % 50.84% 28.78% 26.20% -24.88% 11.30% 29.90% 20.75% 37.21% 561.33% 33.64% 27.19% 27.39% -24.30%
8.15 26.13 22.06 -48.53 23.46 27.48 16.00 29.79 3.46 14.38 43.05 29.07 -4.92
EPS in Rs 0.60 2.35 2.05 -4.83 1.89 2.48 1.33 2.68 0.32 1.41 4.05 2.64 -0.87
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
397 345 407 547 798 815 899 689 577 747 752 770
285 273 304 391 596 618 739 566 471 629 634 620
Operating Profit 111 71 103 156 203 197 160 123 107 118 117 151
OPM % 28% 21% 25% 29% 25% 24% 18% 18% 18% 16% 16% 20%
14 28 20 24 12 -8 35 26 20 -42 18 -0
Interest 10 18 16 19 20 23 4 8 6 5 10 7
Depreciation 6 11 11 13 20 21 9 13 17 17 19 26
Profit before tax 109 71 96 148 175 145 182 129 104 54 106 117
Tax % 46% 42% 36% 32% 36% 39% 30% 26% 29% 57% 28% 30%
60 41 61 100 113 89 127 95 74 23 77 82
EPS in Rs 5.60 3.97 5.81 8.00 7.95 5.70 11.99 9.43 6.64 1.45 6.80 7.21
Dividend Payout % 12% 13% 12% 6% 8% 18% 8% 5% 8% 34% 7% 7%
Compounded Sales Growth
10 Years: 8%
5 Years: -3%
3 Years: 10%
TTM: 2%
Compounded Profit Growth
10 Years: 9%
5 Years: -6%
3 Years: 11%
TTM: 33%
Stock Price CAGR
10 Years: 7%
5 Years: -8%
3 Years: -2%
1 Year: 28%
Return on Equity
10 Years: 13%
5 Years: 9%
3 Years: 7%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 10 10 10 10 10 10 10 10 10 10 10 10
Reserves 248 277 327 402 476 526 636 725 798 808 873 957
148 173 160 132 225 118 102 126 122 109 102 100
165 123 166 218 311 206 157 168 147 181 171 147
Total Liabilities 571 583 662 762 1,023 860 905 1,030 1,077 1,109 1,157 1,214
168 213 234 225 305 143 146 242 234 281 379 370
CWIP 1 4 0 9 4 0 47 0 2 22 3 8
Investments 0 0 0 0 0 0 0 0 0 2 8 4
402 365 428 527 714 717 712 788 840 803 768 832
Total Assets 571 583 662 762 1,023 860 905 1,030 1,077 1,109 1,157 1,214

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
6 41 38 113 289 18 40 47 64 135 34 152
-124 -11 -29 -50 -249 48 -79 -40 -45 -103 -6 -133
110 -8 -42 -40 -10 -76 17 -6 -21 -24 -25 -21
Net Cash Flow -8 22 -34 23 30 -10 -22 0 -2 9 3 -1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 225 228 222 201 116 134 187 290 293 192 187 192
Inventory Days 58 70 69 55 50 55 46 64 110 116 94 113
Days Payable 212 176 165 153 100 55 47 75 82 86 79 58
Cash Conversion Cycle 71 121 126 102 67 134 186 279 321 221 202 247
Working Capital Days 130 146 160 125 76 182 180 269 319 219 221 233
ROCE % 35% 20% 23% 31% 29% 27% 26% 18% 12% 14% 12%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
33.24% 33.19% 33.14% 33.14% 34.51% 34.55% 34.46% 35.04% 35.12% 35.06% 34.97% 34.97%
21.24% 21.01% 19.59% 17.33% 17.17% 16.68% 16.53% 16.60% 16.50% 16.31% 15.35% 14.74%
6.72% 6.67% 6.66% 6.66% 6.65% 6.64% 6.63% 6.63% 6.62% 6.61% 6.60% 6.59%
38.80% 39.13% 40.61% 42.87% 41.67% 42.13% 42.35% 41.73% 41.73% 42.00% 43.08% 43.71%
No. of Shareholders 39,99942,74241,08045,86646,32745,75344,98343,04142,18243,23440,75845,157

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls